This Hyperfine Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday
Avi Kapoor 6 months ago
NewsInitiationMarketsAnalyst RatingsTrading Ideas
Top analysts change outlook on Hyperfine Inc, Legence, and Aktis Oncology with Buy/Outperform ratings and price targets. See other analysts' views.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- BTIG analyst Marie Thibault initiated coverage on Hyperfine Inc (NASDAQ:HYPR) with a Buy rating and announced a price target of $2. Hyperfine shares closed at $1.30 on Tuesday. See how other analysts view this stock.
- Loop Capital analyst Jeffrey Stevenson initiated coverage on Legence (NASDAQ:LGN) with a Buy rating and announced a price target of $96. Legence shares closed at $80.58 on Tuesday. See how other analysts view this stock.
- William Blair analyst Alexandra Ramsey initiated coverage on Aktis Oncology, Inc. (NASDAQ:AKTS) with an Outperform rating. Aktis Oncology shares closed at $18.60 on Tuesday. See how other analysts view this stock.
Considering buying HYPR stock? Here’s what analysts think:
Photo via Shutterstock